Loading clinical trials...

Validation of iPelvis App for Female Pelvic Floor Dysfunction | Clinical Trials | Clareo Health

COMPLETEDNA

Validation of iPelvis App for Female Pelvic Floor Dysfunction

Validation of the iPelvis Mobile Application for Pelvic Physiotherapy in Women With Female Pelvic Floor Dysfunction

NCT04484753•Rogério de Fraga

Summary

The iPelvis app aims to improve adherence to pelvic physiotherapy on women with pelvic floor related dysfunctions, such as urinary or fecal incontinence, sexual dysfunction, etc.

Detailed Description

Urinary dysfunctions are widely discussed because they cause problems in social, emotional, sexual life and the quality of life of incontinent women. The overall objective of this research is to evaluate the use of the Application. Ipelvis in women with urinary incontinence. This is a longitudinal study of the type randomized controlled trial. Women with urinary incontinence of urgency, effort and effort will be evaluated and treated. Frequently asked questions, questions and answers, Quality of Life Questionnaires, Health Requirements, ICIQ-SF, ICIQ-OAB, FSFI and evaluation of pelvic, manual and electromyographic floor musculature function. As volunteers are drawn in four groups (Group I: Household Exercise Sheet / Group II: Ipelvis application / Group III: Household Exercise Sheet + Pelvic Physiotherapy / Group IV Ipelvis Application + Pelvic Physiotherapy).

Eligibility

Age

18 - 59 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Women with urinary incontinence by urodynamics, stress and mixed urinary incontinence, aged between 18 and 59 years, who have cognitive ability, have a compatible cell to install the Ipelvis application and who sign the Informed Consent Form.

Exclusion Criteria

•Pregnant women, women up to six months postpartum, women with prolapse greater than stage III by Pelvic Organ Prolapse - Quantification (POP-Q), women with urinary tract infection, women with pelvic pain Performing therapies offered or having undergone pelvic surgery within a period of less than six months; With a pacemaker or contraceptive device (IUD); Women with intrapelvic tumor.

Key Dates

Start Date

January 9, 2017

Primary Completion Date

July 1, 2018

Completion Date

December 1, 2018

Last Updated

July 24, 2020

Enrollment

138

ACTUAL participants

Conditions

Female Sexual DysfunctionUrinary Incontinence

Interventions

Home Exercise Sheet

OTHER

Ipelvis mobile application

OTHER

Home exercise sheet + Pelvic Physiotherapy

BEHAVIORAL

Ipelvis mobile application + Pelvic Physiotherapy

BEHAVIORAL

TReating Incontinence for Underlying Mental and Physical Health

NCT05362292

Urinary Incontinence, UrgeUrinary Incontinence+4 more

View study

RECRUITINGNA

Efficacy of a Video-Based Educational Program on Female Urinary Incontinence

NCT07105150

Urinary Incontinence

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 24, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Validation of iPelvis App for Female Pelvic Floor Dysfunction

Inclusion Criteria

Exclusion Criteria

TReating Incontinence for Underlying Mental and Physical Health

Efficacy of a Video-Based Educational Program on Female Urinary Incontinence

Muscle Fiber Fragment Treatment for Urinary Incontinence

Training for Urinary Leakage Improvement After Pregnancy

Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study)

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence